The partial pressure of arterial oxygen (PaO 2 ) dissolved in the plasma contributes 101 little to the total content of arterial oxygen (CaO 2 ; Figure 1) 
Introduction
a given severity of isocapnic hypoxia, blood flow to the brain stem increases more than 147 that to the middle and anterior regions, as assessed by flow through the vertebral and 148 internal carotid arteries, respectfully (75, 116, 139, 199) . Data collected using congruous 149 PET scan during isocapnic hypoxia also indicate that cortical blood flow is less 150 responsive to hypoxia than phylogenetically older areas of the brain (18). Although the 151 cerebral areas responsible for increased blood flow to hypoxia were traditionally thought 152 to fall exclusively at the small pial vessels (207), recent data now indicates that cerebral 153 vasodilation also occurs at the larger intra-cranial cerebral (e.g., MCA) (88, 201, 203 ) and 154 extra-cranial cerebral vessels (e.g., internal carotid artery & vertebral artery) (116). This 155 dilation has been observed when SaO 2 falls to ~80% for both the large intra-(88) and 156 extra-(116) cranial cerebral vessels.
157
Although the underlying mechanisms have not been fully elucidated in awake 158
humans (see section "Signaling pathways in the regulation of CBF during hypoxia"), 159 upon re-analysis of the key studies to date (see Figure 2) , the elevation in CBF in 160 response to acute hypoxemic hypoxia seems to be entirely appropriate to maintain CDO 2 .
161
When CDO 2 is maintained, both cerebral oxygen extraction (%) and CMRO 2 are also 162 unchanged (4). However, if CDO 2 were to become reduced, then oxygen extraction has 163 the capacity to almost double to compensate. The CDO 2 and cerebral oxygen extraction 164 fraction can be calculated as per equations 1 and 2: 165 166
(1) CDO 2 (mL · min Where CDO 2 represents cerebral oxygen delivery, gCBF represents global cerebral blood 171 flow, CaO 2 represents the arterial content of oxygen, and CjvO 2 represents the jugular 172 venous content of oxygen.
173
While global CDO 2 is maintained during hypoxemic hypoxia, there appears to be 174 a moderately heterogeneous response throughout the brain, related to regional disparities 175 in CBF and hypoxic reactivity ( Figure 3 ) and an overall drop in tissue PO 2 (as inferred 176 from jugular venous PO 2 ) (4). These disparities in the maintenance of CDO 2 , and thus 177 specific regional variations in tissue PO 2 , in concert with selective vulnerability of 178 specific regions (i.e., selective neuronal vulnerability) to hypoxia (149) are likely 179 implicated in cerebral dysfunction (e.g., reduced cognitive capacity 
362
When assessing the long-term influence of CaO 2 from altered hemoglobin mass in 363 anemia and polycythemia, it is apparent that CDO 2 is not impaired ( Figure 6 ). Indeed, 364 patients with anemia possess a relatively high CBF that maintains CDO 2 despite reduced 365
CaO 2 , and the reduction in CBF that is typical of polycythemic patients is not large 366 enough to reduce CDO 2 , which appears to remain normal in these patients. 367
In In contrast to during hypoxemic hypoxia, data in humans (33, 47, 73, 130) and 624 animals (181, 182) (Figure 9 ) indicate that CDO 2 is impaired during reductions in CaO 2 625 via hemodilution. This may be due to a reduced signal transduction of processes 626 originating from the erythrocyte, due to: 1) a reduction of total hemoglobin levels during 627 hemodilution compared to hypoxemic hypoxia, and 2) a reduction of deoxyhemoglobin 628 produced from gas exchange with cerebral tissue during hemodilution compared to 629 hypoxemic hypoxia (i.e., smaller percentage of deoxyhemoglobin). In humans, during 630 hemodilution, jugular venous saturation is not appreciably reduced (<3% change) 631 compared to baseline (33, 142), whereas during hypoxemic hypoxia jugular venous 632 saturation is reduced progressively (up to ~20%) with increases in severity (4). The 633
higher SaO 2 during hemodilution would result in reduced deoxyhemoglobin mediated 634 ATP release, nitrite reductase activity, and NO release from SNO (117). Furthermore, 635 Tomiyama et al., 1999 (182) showed in a rat model that majority of the difference in the 636 CBF response between hypoxemic hypoxia and hemodilution is due to increased 637 conductance of K ATP channels (182), which are largely responsible for ATP mediated 638 dilation through vascular smooth muscle hyperpolarization (40, 102, 213). The CBF 639 response during hemodilution may also be blunted in part from the reduced blood 640 viscosity, and therefore the reduced shear (106), which could hinder endothelial mediated 641 NO release (34, 141, 197, 208) .
642
Although the CBF response to a reduced CaO 2 is impaired during hemodilution, it 643 is not abolished; thus, it seems that some regulatory mechanisms remain intact. Animal 644 studies suggests that NO is a primary factor mediating the CBF response to hemodilution 645 predominantly through upregulation of neuronal nitric oxide synthase (81, 125). elucidation of these mechanistic CBF relationships is paramount to our comprehension of 668 myriad pathologies associated with arterial hypoxemia (e.g., sleep apnea, chronic lung 669 diseases, and heart failure) and/or alterations in blood viscosity or hemoglobin levels 670 (e.g., anemic or polycythemic pathologies including von Hippel-Landau or Chuvash 671 diseases). Uncovering the molecular basis of hypoxic adaptation in humans will both 672 inform understanding of hematological and other adaptations involved in hypoxia 673 tolerance and form the basis of novel methods for treating conditions of pathological 674 brain hypoxia. Optimizing CDO 2 via multi-modal imaging and/or molecular approaches 675 may provide new insight into the treatment of many hypoxemic, anemic, or polycythemic 676 pathologies and that associated with cerebrovascular complications. 677 678 Conclusion 679 680
During hypoxemic hypoxia at both sea-level and high altitude in healthy humans, 681 elevations in CBF are intimately matched to reductions in CaO 2 in order to maintain 682 CDO 2 . Studies employing hemodilution, and those of patients with anemia and 683 polycythemia, support the notion that CaO 2 has an independent influence on CBF; yet, in 684 the majority of cases when CaO 2 is reduced by hemodilution, CDO 2 is compromised. The 685 mechanisms regulating CBF during changes in CaO 2 are multifactorial but primarily 686 triggered by deoxygenation of hemoglobin (R → T allosteric shift) and consequent 687 erythrocyte release of ATP and SNO, and deoxyhemoglobin nitrite reductase activity. 
